| Home of the International Scleroderma Network (ISN) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| We deliver stellar research, support, education and awareness for scleroderma and related autoimmune and skin diseases worldwide. We are a nonprofit 501(c)(3) public charity, based in the U.S. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dartmouth researchers discover gene signatures for scleroderma. Distinct genetic profiles can discern different groups of patients with scleroderma. This discovery of distinguishing molecular subtypes within the disease offers new insight into the complexity of a poorly understood and hard to treat illness and opens a window for better diagnosis and targeted therapies. Genetic Engineering & Biotechnology News. July 15, 2008. (Also see: Causes of Scleroderma and Types of Scleroderma) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RESEARCH | SUPPORT | EDUCATION | AWARENESS | ISN | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




